Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hartmann

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
Medical and Pediatric Oncology|January 1, 1987
Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patientsO Hartmann, J Lumbroso, J Lemerle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
Medical and Pediatric Oncology|January 1, 1994
What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?C Labreveux de Cervens, O Hartmann, F Bonnin, et al.
Progress in Clinical and Biological Research|January 1, 1991
VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie PédiatriqueD Frappaz, J Michon, O Hartmann, et al.
Journal of the National Cancer Institute|June 1, 1986
Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemiaJ L Pico, O Hartmann, D Maraninchi, et al.
Cancer Research|April 1, 1993
Chronopharmacology of high-dose busulfan in childrenG Vassal, D Challine, S Koscielny, et al.
Cancer|July 15, 1996
The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric OncologyD Plantaz, H Rubie, J Michon, et al.
Cancer Research|October 1, 1990
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological studyG Vassal, A Deroussent, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphomaT Philip, O Hartmann, P Biron, et al.
Archives Francaises De Pediatrie|February 1, 1990
[Neonatal Pepper's syndrome. Apropos of a series of 22 cases]C Labreveux de Cervens, O Hartmann, D Valteau, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
Medical and Pediatric Oncology|January 1, 1987
Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patientsO Hartmann, J Lumbroso, J Lemerle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
Medical and Pediatric Oncology|January 1, 1994
What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?C Labreveux de Cervens, O Hartmann, F Bonnin, et al.
Progress in Clinical and Biological Research|January 1, 1991
VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie PédiatriqueD Frappaz, J Michon, O Hartmann, et al.
Journal of the National Cancer Institute|June 1, 1986
Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemiaJ L Pico, O Hartmann, D Maraninchi, et al.
Cancer Research|April 1, 1993
Chronopharmacology of high-dose busulfan in childrenG Vassal, D Challine, S Koscielny, et al.
Cancer|July 15, 1996
The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric OncologyD Plantaz, H Rubie, J Michon, et al.
Cancer Research|October 1, 1990
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological studyG Vassal, A Deroussent, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphomaT Philip, O Hartmann, P Biron, et al.
Archives Francaises De Pediatrie|February 1, 1990
[Neonatal Pepper's syndrome. Apropos of a series of 22 cases]C Labreveux de Cervens, O Hartmann, D Valteau, et al.
Pageof 26